Firefly Neuroscience Inc.
AIFF | NASDAQ
$1.20
-$0.03 (-2.44%)
At close: Sep 22, 2026, 4:00 PM ET
$1.15
-$0.05 (-4.14%)
After-hours:
Sep 22, 2026, 7:36 PM ET
Company Profile
Based in Toronto, Canada, Firefly Neuroscience, Inc. is a medical technology and artificial intelligence firm specializing in developing neuroscientific solutions. The company's primary goal is to enhance patient outcomes for individuals affected by mental illnesses and neurological disorders. Its flagship product, Brain Network Analytics, is a sophisticated software platform engineered to aid in the diagnosis and treatment of a diverse range of cognitive and psychiatric conditions. These conditions encompass, but are not limited to, depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. Firefly Neuroscience, Inc. caters to both pharmaceutical companies and medical practitioners.
Key Executives
| Name | Position |
|---|---|
| Greg Lipschitz | Chief Executive Officer & Director |
| David DeCaprio | President, Chief Operating Officer & Director |
| Paul Krzywicki | Chief Financial Officer & Company Secretary |
| Gil Issachar | Head of AI & Neuroscience |
Firefly Neuroscience Inc.
| Country | United States |
| IPO Date | Nov 27, 2002 |
| Industry | Software - Application |
| Sector | Technology |
| Employees | 17 |
| CEO | Greg Lipschitz |
Contact Details
1100 Military Road Kenmore,
New York 14217 United States
Stock Details
| Ticker Symbol | AIFF |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0000803578 |
| CUSIP Number | 317970101 |
| ISIN Number | US3179701012 |
| SIC Code | n/a |
Add to Watchlist
Select watchlists to add or remove AIFF